Last update 10 Nov 2024

Volrubigene Ralaparvovec

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
AAV-UGT1A1, AT 342, AT-342
+ [1]
Target
UGT1A1
Mechanism
UGT1A1 modulators(UDP-glucuronosyltransferase 1-1 modulators), Gene transference
Therapeutic Areas
Congenital DisordersEndocrinology and Metabolic DiseaseOther Diseases
Active Indication
Crigler-Najjar Syndrome
Inactive Indication-
Originator Organization
Astellas Gene Therapies, Inc.Astellas Gene Therapies, Inc.
Active Organization
Astellas Gene Therapies, Inc.Astellas Gene Therapies, Inc.
Inactive Organization
University of PennsylvaniaUniversity of Pennsylvania
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Volrubigene Ralaparvovec
NCT03223194 / TerminatedPhase 1
VALENS: A Phase 1/2, Randomized, Open-Label, Ascending-Dose, Delayed-Treatment Concurrent Control Clinical Study to Evaluate the Safety and Preliminary Efficacy of AT342, an AAV8-Delivered Gene Transfer Therapy in Crigler-Najjar Syndrome Subjects Aged 1 Year and Older
100 Clinical Results associated with Volrubigene Ralaparvovec
Login to view more data
100 Translational Medicine associated with Volrubigene Ralaparvovec
Login to view more data
100 Patents (Medical) associated with Volrubigene Ralaparvovec
Login to view more data
100 Deals associated with Volrubigene Ralaparvovec
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Crigler-Najjar SyndromePhase 2
US
Astellas Gene Therapies, Inc.Astellas Gene Therapies, Inc.
01 May 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free